CTSO vs PKI
Cytosorbents Crp (CTSO) versus PKI (PKI) — a side-by-side from cached financials, not a winner call.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
PKI (PKI) common stock.
Latest reported CTSO revenue for 2026-06-30 was $18.5M. Net income was -$9.5M. CTSO currently screens at market cap $28.8M.
PKI does not have a complete income-statement cache yet.
CTSO currently screens at market cap $28.8M.
Not investment advice. Open the CTSO and PKI stock pages for the full models.
Not investment advice.